Saturday, 31 October 2026European Markets

PARROT Stock Drops By 16% In The Last 5 Sessions

Loading stream...

paris is the hub of many world-renowned conglomerates and enterprises contributing variously to the global markets. among the many, our today's key subject is parrot s.a. (parro.pa), a well-known drone manufacturer and software provider. recently, this company has become a topic of conversation due to some notable changes in its share market performance.

parro.pa performance in the stock market

the share prices of parrot s.a. experienced a severe drop by 16.55% over five trading sessions, depreciating from eur4.35 to eur3.63. this change mirrors the 1.58% decline of france's benchmark stock market index cac 40, which recently nosedived to eur7,288.73. the company's share price ended recently at eur3.72, marking a significant decline of 33.57%, lower than its 52-week high of eur5.60.

parrot’s contribution to the global market

in spite of the recent downswings, let's not forget the distinctive services that parrot s.a. offers. serving worldwide, they provide professional drones besides their software services. they engage particularly with inspection industries, emergency first responders, security agencies, and surveyors. their footprint is noticeably intensive in france, where they provide advanced software tools for drone programming and 3d photorealistic simulation.

the financial standpoint of parro.pa

the financial standing of parrot s.a. might offer an insight into the recent events. the company currently shows an annual trailing twelve-month earnings per share deficit of eur-0.66. it indicates that it hasn't made a profit during this period, which could be a potential reason for the latest sell-offs leading to the price drops.

trading volume state of parro.pa

the trading volume of parrot s.a. has been extremely low recently. the number of shares that have changed hands is only 2,872, showing a huge decrease of 68.42% when compared to its average daily volume of 7,413.

the future of parro.pa

with these unexpected alterations, investors and market observers are probably more interested in the future performance and trading trends of parrot s.a. it will indeed be intriguing to see how the company navigates through these challenging times to re-establish its market position and regain investors' confidence.

more news about parrot (parro.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com